tiprankstipranks
Corvus Pharmaceuticals Inc (CRVS)
NASDAQ:CRVS

Compare Corvus Pharmaceuticals (CRVS) vs. Competitors

682 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Corvus Pharmaceuticals
$14.88
$1.25B
-39.78
427.66%
5 Buy
0 Hold
0 Sell
Strong Buy
Altimmune
$3.37
$438.34M
-3.32
-8.17%
5 Buy
1 Hold
0 Sell
Strong Buy
Rigel
$29.73
$549.21M
2.10
81.61%
2 Buy
2 Hold
0 Sell
Moderate Buy
Neurogene
$21.61
$336.56M
-4.83
194.41%
7 Buy
0 Hold
0 Sell
Strong Buy
Rocket Pharmaceuticals
$3.60
$390.85M
-2.29
-24.84%
7 Buy
4 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CRVS
Corvus Pharmaceuticals
14.88
11.94
406.12%
ALT
Altimmune
3.37
-0.86
-20.33%
RIGL
Rigel
29.73
12.47
72.25%
NGNE
Neurogene
21.61
12.58
139.31%
RCKT
Rocket Pharmaceuticals
3.60
-1.80
-33.33%
ATXS
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts